The sulfhydryl group (-SH) on the cysteine residue of the glutathione molecule is the reactive component required for this reaction
Studies have indicated a positive correlation between TMAO levels and various chronic non-communicable diseases, including insulin resistance, atherosclerotic plaque formation, diabetes, cancer, heart failure, hypertension, chronic kidney disease, liver disease, neurodegeneration, and Alzheimers disease (Coutinho-Wolino et al., 2021)
All prescribing at Peptides Thailand is done on an investigational basis following individual physician assessment of the patient's GI history, current medications, and clinical goals
None constitute a claim regarding this product
Muscle: 250 to 500 mcg once or twice daily, subcutaneous near the muscle, 4 to 8 weeks